Concepedia

Publication | Open Access

Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial

13

Citations

17

References

2023

Year

Abstract

Pimavanserin significantly reduced risk of psychosis relapse in patients with PDD, was well tolerated, and did not worsen motor or cognitive function.

References

YearCitations

Page 1